| Phospho-specific Flow: Fixating on the target. | |
| | |
MedLine Citation:
|
PMID: 22302900 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Targeted therapies are all the rage in oncology research these days. The problem remains as to how to confirm that the target is actually being hit in vivo. This report describes the application of phospho-specific flow cytometry to establish in vivo target inhibition in real-time. |
| | |
Authors:
|
Mark Levis |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-2-2 |
Journal Detail:
|
Title: Clinical cancer research : an official journal of the American Association for Cancer Research Volume: - ISSN: 1078-0432 ISO Abbreviation: - Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-2-3 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9502500 Medline TA: Clin Cancer Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Oncology, Johns Hopkins University. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Molecular Pathways : microsatellite instability in colorectal cancer: prognostic, predictive and the...
Next Document: Comparing Retrospective Reports to Real-Time/Real-Place Mobile Assessments in Individuals With Schiz...